-
NSE
2,207.00 2,207.00(%) -
SBI
1,159.70 1,234.80(%) -
One 97
1,664.70 947.10(%) -
Billionbrains
218.00 142.05(%) -
LG Electronics
1,725.00 1,835.00(%) -
Bharat Forge
1,734.40 2,293.00(%) -
Maruti Suzuki
13,619.60 17,371.60(%) -
Reliance Industries
1,381.95 1,611.20(%) -
Samvardh. Mothe.
165.00 173.25(%) -
Coforge
2,055.35 2,127.30(%) -
ICICI Bank
1,608.75 1,616.70(%) -
Black Box
933.85 1,104.30(%) -
Bharti Airtel
2,159.95 2,174.70(%) -
Cipla
1,406.95 1,165.55(%) -
M & M
3,524.50 3,840.00(%) -
IndusInd Bank
924.50 1,077.80(%) -
Max Financial
1,383.90 1,173.40(%) -
HDFC Bank
822.10 1,017.90(%) -
Tube Investments
2,247.35 3,335.00(%) -
Mah. Seamless
497.00 493.15(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Piramal Pharma Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln
- Piramal Ajay G
- BSE Code : 76066.0
- ISIN : INE0DK501011
-
Today’s Low
235.33 -
Today’s High
240.95
-
Open
238.00 -
Perv Close
238.95 -
52W Low
132.30 -
52W High
253.90
Key Indicators
-
P/E(TTM)
42.60
-
Mar.Cap (₹Cr.)
31,905.76
-
Div & Yield %
0.00
-
Book Value(₹)
63.50
-
Debt-Equity Ratio
0.29
-
AGM Date
19-Nov-2026
-
EPS
5.62
-
P/E Ratio
42.60
Financials Ratios
-
Debt-Equity Ratio
0.70
-
Mar.Cap (₹Cr.)
31,905.76
-
RONW (%)
0.22
-
ROCE (%)
5.40
Score Board
-
Equity (₹ in Cr.)
1,331.35
-
BV (₹)
63.50
-
Sales( ₹ in Cr.)
4,782.01
-
NP (in Cr.)
767.53
-
NP Var(%)
11.0
-
Div%
0.0
-
CPS (₹)
7.70
-
EPS (₹)
5.80
-
Traded Value (₹ in Lakhs)
31,872.47
-
52 Week High
253.90
-
52 Week Low
132.30
-
Price BSE
239.0
-
Price NSE
240.00
-
Market Capital( in Cr.)
31,872.47
-
P/C Ratio
31.10
-
P/E Ratio
41.50
-
Price Vs.BV
5.80
-
28-Oct-2026( 02:40)
Hot Pursuit - Volum... - <p>United Breweries Ltd, Synge...
-
28-Oct-2026( 01:05)
Hot Pursuit - Piram... - <p>Piramal Pharma Ltd is up fo...
-
28-Oct-2026( 12:00)
Hot Pursuit - Piram... - <p>Lumax Auto Technologies Ltd...
-
28-Oct-2026( 10:27)
Results - Announcements - Piram... - <p>Piramal Pharma Ltd share pr...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)| Particulars(INCOME) | 2026 Mar | 2025 Mar | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar |
|---|---|---|---|---|---|---|
| INCOME : | ||||||
| Sales Turnover | 4,782.01 | 5,285.71 | 4,390.11 | 3,443.22 | 3,340.42 | 2,938.81 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 4,782.01 | 5,285.71 | 4,390.11 | 3,443.22 | 3,340.42 | 2,938.81 |
| Other Income | 662.73 | 207.35 | 202.06 | 341.07 | 224.79 | 216.20 |
| Stock Adjustments | 138.98 | 84.57 | 61.62 | -53.31 | 32.66 | -57.86 |
| Total Income | 5,583.72 | 5,577.63 | 4,653.79 | 3,730.98 | 3,597.87 | 3,097.15 |
| EXPENDITURE : | ||||||
| Raw Materials | 2,208.88 | 2,330.53 | 2,170.46 | 1,715.17 | 1,594.17 | 1,169.91 |
| Power and Fuel Cost | 131.53 | 131.62 | 112.89 | 107.94 | 83.83 | 68.08 |
| Employee Cost | 744.82 | 736.19 | 613.93 | 548.50 | 448.03 | 395.15 |
| Other Manufacturing Expenses | 292.60 | 284.35 | 251.57 | 259.29 | 299.83 | 252.74 |
| Selling and Administration Expenses | 746.52 | 746.69 | 620.04 | 485.63 | 427.82 | 258.75 |
| Miscellaneous Expenses | 247.15 | 100.46 | 64.92 | 182.81 | 59.20 | 117.39 |
| Employee Benefit Expenses | 744.82 | 736.19 | 613.93 | 548.50 | 448.03 | 395.15 |
| Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Expenses | 4,371.50 | 4,329.84 | 3,833.81 | 3,299.34 | 2,912.88 | 2,262.02 |
| Operating Profit | 1,212.22 | 1,247.79 | 819.98 | 431.64 | 684.99 | 835.13 |
| Interest | 79.95 | 114.56 | 107.10 | 115.87 | 57.29 | 4.71 |
| Gross Profit | 1,132.27 | 1,133.23 | 712.88 | 315.77 | 627.70 | 830.42 |
| Depreciation | 255.50 | 222.09 | 205.26 | 192.08 | 165.37 | 143.64 |
| Profit Before Tax | 876.77 | 911.14 | 507.62 | 123.69 | 462.33 | 686.78 |
| Current Tax | 114.68 | 199.44 | 112.48 | 38.77 | 110.82 | 104.98 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 62.08 | 20.30 | 3.92 | 15.42 | -16.03 | 10.30 |
| Reported Net Profit | 700.01 | 691.40 | 391.22 | 69.50 | 367.54 | 571.50 |
| Extraordinary Items | -67.52 | 1.46 | 3.34 | -3.14 | -10.64 | 15.44 |
| Adjusted Net Profit | 767.53 | 689.94 | 387.88 | 72.64 | 378.18 | 556.06 |
| Adjustment below Net Profit | -13.89 | 1.05 | -3.79 | -2.59 | 31.70 | -2.46 |
| P & L Balance brought forward | 2,037.21 | 1,359.23 | 971.79 | 918.28 | 569.04 | 0.00 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 18.54 | 14.47 | 0.00 | 13.40 | 50.00 | 0.00 |
| P & L Balance carried down | 2,704.79 | 2,037.21 | 1,359.22 | 971.79 | 918.28 | 569.04 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 0.00 | 1.40 | 1.10 | 0.00 | 5.60 | 0.00 |
| Dividend Per Share(Rs) | 0.00 | 0.14 | 0.11 | 0.00 | 0.56 | 0.00 |
| Earnings Per Share-Unit Curr | 5.27 | 5.22 | 2.96 | 0.58 | 3.10 | 5.75 |
| Earnings Per Share(Adj)-Unit Curr | 5.27 | 5.22 | 2.96 | 0.57 | - | - |
| Book Value | 61.34 | 56.27 | 50.74 | 44.09 | 43.20 | 41.23 |
| Book Value(Adj)-Unit Curr | 61.34 | 56.27 | 50.74 | 43.06 | - | - |
